Treatment of Hepatocellular Carcinoma by Transarterial Injection of Anticancer Agents in Iodized Oil Suspension or of Radioactive Iodized Oil Solution
- 1 March 1986
- journal article
- research article
- Published by SAGE Publications in Acta Radiologica. Diagnosis
- Vol. 27 (2) , 139-147
- https://doi.org/10.1177/028418518602700203
Abstract
Transarterial injection of modified iodized oil was performed in 48 patients with hepatoma. In 41 cases an adriamycin and/or mitomycin C-iodized oil suspension was administered into the proper hepatic artery or peripheral hepatic branches. A reduction in tumor size of over 50 per cent was obtained in 14 of the 33 patients in whom CT examination was performed before and after treatment. Serum alpha-fetoprotein levels decreased in 20 of 21 cases within the first month after injection. The one-year survival rate was estimated at 55 per cent in advanced hepatoma. In 7 patients, transarterial internal irradiation using radioactive iodized oil was carried out. A decrease in tumor size was observed in all cases and in alpha-fetoprotein levels in 6 cases. One patient with severe liver cirrhosis died in hepatorenal failure. No severe complications or other adverse reactions were encountered with either of the methods.This publication has 6 references indexed in Scilit:
- Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.Radiology, 1985
- Hepatocellular carcinoma detected by iodized oil.Radiology, 1985
- Hepatocellular carcinoma and metastatic cancer detected by iodized oil.Radiology, 1985
- Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary reportEuropean Journal of Cancer and Clinical Oncology, 1983
- Work in progress: intra-arterial P-32 chromic phosphate for prevention of postoperative liver metastases in high-risk colorectal cancer patients.Radiology, 1983
- Whole-Lung Irradiation for Metastatic TumorRadiology, 1969